Petros Pharmaceuticals's total assets for Q3 2025 were $6.13M, a decrease of -17.08% from the previous quarter. PTPI total liabilities were $2.77M for the fiscal quarter, a -6.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.